Haight, P. J., Sanchez, M., Thomas, S. M., Smitherman, C., Cosgrove, C., Bae-Jump, V., Crafton, S., Hacker, K., Ko, E., Krivak, T., Lara, O., Moore, K., Mullen, M. M., Pothuri, B., Thaker, P. H., Washington, C., Arend, R., Corr, B., Duska, L., … Backes, F. (2025). Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study. Gynecologic Oncology, 194, 98–104. https://doi.org/10.1016/j.ygyno.2025.02.013

Nolin, A. C., Atkins, S. L., Myers, E. R., Wentzensen, N., Clarke, M. A., Blank, S. V., Wright, J. D., Doll, K. M., & Havrilesky, L. J. (2025). Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals. Gynecologic Oncology, 194, 105–111. https://doi.org/10.1016/j.ygyno.2025.02.006

Matsuo, K., Agarwal, J., Chen, L., Furey, K. B., Song, B. B., Pino, C., Matsuzaki, S., Suzuki, Y., Klar, M., Roman, L. D., & Wright, J. D. (2025). Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer. Gynecologic Oncology, 194, 51–59. https://doi.org/10.1016/j.ygyno.2025.02.012

Nagase, Y., Matsuo, K., Nakao, Y., Hisa, T., Kamiura, S., Yokoi, T., Roman, L. D., Wright, J. D., & Matsuzaki, S. (2024). Adjuvant therapy de-escalation for stage I uterine leiomyosarcoma: A systematic review and meta-analysis. Gynecologic Oncology, 191, 219–227. https://doi.org/10.1016/j.ygyno.2024.10.018

Britton, M. C., Izampuye, E., Clark, M., Ornstein, R. A., Nunez-Smith, M., Wright, J. D., & Xu, X. (2024). Diagnostic experiences of Black and White patients with uterine cancer: A qualitative study. Gynecologic Oncology, 191, 67–73. https://doi.org/10.1016/j.ygyno.2024.09.010

Lemieux, M., Telles, R., Goodheart, M., Dahmoush, L., Hagemann, I., Penedo, F. J., Nandakumar, R., Cole, S. W., Sood, A. K., Lutgendorf, S. K., & Thaker, P. H. (2024). Quality of life and survivorship in patients with low-grade ovarian cancer. Gynecologic Oncology, 190, 96–103. https://doi.org/10.1016/j.ygyno.2024.08.010

Suzuki, Y., Chen, L., Matsuo, K., Ferris, J. S., Elkin, E. B., Melamed, A., Kong, C. Y., Bickell, N., Myers, E. R., Havrilesky, L. J., Xu, X., Blank, S. V., Hazelton, W. D., Hershman, D. L., & Wright, J. D. (2024). Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecologic Oncology, 190, 78–83. https://doi.org/10.1016/j.ygyno.2024.08.003

Gamble, C. R., Huang, Y., Quinn, J., Melamed, A., Rundle, A., & Wright, J. D. (2024). Neighborhood economic vulnerability as a predictor for patterns of care and outcomes for patients with uterine cancer. Gynecologic Oncology, 190, 70–77. https://doi.org/10.1016/j.ygyno.2024.07.671

Matsuo, K., Chen, L., Klar, M., Lee, M. W., Machida, H., Mikami, M., Muderspach, L. I., Carlson, J. W., Roman, L. D., & Wright, J. D. (2024). Prognostic performance of the 2023 FIGO staging schema for endometrial cancer. Gynecologic Oncology, 187, 37–45. https://doi.org/10.1016/j.ygyno.2024.04.016

Ferris, J. S., Prest, M. T., Hur, C., Chen, L., Elkin, E. B., Melamed, A., Kong, C. Y., Myers, E. R., Havrilesky, L. J., Blank, S. V., Hazelton, W. D., & Wright, J. D. (2024). Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects. Gynecologic Oncology, 187, 151–162. https://doi.org/10.1016/j.ygyno.2024.04.026

Bergstein, A., Huang, Y., Hershman, D. L., Xu, X., & Wright, J. (2024). Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis. Gynecologic Oncology, 189, 49–55. https://doi.org/10.1016/j.ygyno.2024.06.028

Matsuo, K., Huang, Y., Matsuzaki, S., Vallejo, A., Ouzounian, J. G., Roman, L. D., Khoury-Collado, F., Friedman, A. M., & Wright, J. D. (2024). Cesarean hysterectomy for placenta accreta spectrum: Surgeon specialty-specific assessment. Gynecologic Oncology, 186, 85–93. https://doi.org/10.1016/j.ygyno.2024.04.004

Huang, Y., Rauh-Hain, J. A., McCoy, T. H., Hou, J. Y., Hillyer, G., Ferris, J. S., Hershman, D., Wright, J. D., & Melamed, A. (2024). Comparing survival of older ovarian cancer patients treated with neoadjuvant chemotherapy versus primary cytoreductive surgery: Reducing bias through machine learning. Gynecologic Oncology, 186, 9–16. https://doi.org/10.1016/j.ygyno.2024.03.016

Dinicu, A. I., Dioun, S., Wang, Y., Huang, Y., Wright, J. D., & Tergas, A. I. (2024). Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care. Gynecologic Oncology, 184, 214–223. https://doi.org/10.1016/j.ygyno.2024.01.043

Dioun, S., Chen, L., De Meritens, A. B., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Pua, T., Hershman, D. L., & Wright, J. D. (2024). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy. Gynecologic Oncology, 182, 70–74. https://doi.org/10.1016/j.ygyno.2023.12.027

Xu, X., Chen, L., Nunez-Smith, M., Clark, M., Ferris, J. S., Hershman, D. L., & Wright, J. D. (2024). Black-White differences in uterine cancer symptomatology and stage at diagnosis. Gynecologic Oncology, 180, 118–125. https://doi.org/10.1016/j.ygyno.2023.11.029

Hsieh, K., Bloom, J. R., Dickstein, D. R., Hsieh, C., Marshall, D., Ghiassi-Nejad, Z., Raince, J., Lymberis, S., Chadha, M., & Gupta, V. (2024). Dose and fractionation regimen for brachytherapy boost in cervical cancer in the US. Gynecologic Oncology, 180, 55–62. https://doi.org/10.1016/j.ygyno.2023.11.014

Suzuki, Y., Chen, L., Ferris, J. S., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Pua, T., de Meritens, A. B., Accordino, M., Hershman, D. L., & Wright, J. D. (2024). Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer. Gynecologic Oncology, 180, 14–23. https://doi.org/10.1016/j.ygyno.2023.11.010

Andriani, L., Oh, J., McMinn, E., Gleason, E., Koelper, N. C., Chittams, J., Simpkins, F., & Ko, E. M. (2023). Telehealth utilization in gynecologic oncology clinical trials. Gynecologic Oncology, 177, 103–108. https://doi.org/10.1016/j.ygyno.2023.08.011

Lee, M. W., Vallejo, A., Mandelbaum, R. S., Yessaian, A. A., Pham, H. Q., Muderspach, L. I., Roman, L. D., Klar, M., Wright, J. D., & Matsuo, K. (2023). Temporal trends of failure-to-rescue following perioperative complications in vulvar cancer surgery in the United States. Gynecologic Oncology, 177, 1–8. https://doi.org/10.1016/j.ygyno.2023.08.002

Whelan, K., Dillon, M., Strickland, K. C., Pothuri, B., Bae-Jump, V., Borden, L. E., Thaker, P. H., Haight, P., Arend, R. C., Ko, E., Jackson, A. L., Corr, B. R., Ayoola-Adeola, M., Wright, J. D., Podwika, S., Smitherman, C., Thomas, S., Lightfoot, M., Newton, M., … Alvarez Secord, A. (2023). TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes. Gynecologic Oncology, 178, 44–53. https://doi.org/10.1016/j.ygyno.2023.09.009

Agustí, N., Viveros-Carreño, D., Mora-Soto, N., Ramírez, P. T., Rauh-Hain, A., Wu, C.-F., Rodríguez, J., Grillo-Ardila, C. F., Salazar, C., Jorgensen, K., Segarra-Vidal, B., Chacón, E., Melamed, A., & Pareja, R. (2023). Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer: A systematic review and meta-analysis. Gynecologic Oncology, 177, 157–164. https://doi.org/10.1016/j.ygyno.2023.08.019

Kulkarni, A., Nchako, C., Ahsan, M. D., Bhoj, C., Dioun, S., Webster, E., Cantillo, E., Chapman-Davis, E., Holcomb, K., & Frey, M. (2023). Can we talk about sex? Universal sexual health screening for cancer survivors and previvors with hereditary breast and ovarian cancer syndromes (2188). Gynecologic Oncology, 176, S249. https://doi.org/10.1016/j.ygyno.2023.06.309

Diggs, A., Dioun, S., Chen, L., St. Clair, C., de Meritens, A. B., Hou, J., Khoury-Collado, F., & Wright, J. (2023). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy (2204). Gynecologic Oncology, 176, S259. https://doi.org/10.1016/j.ygyno.2023.06.324

Praiss, A., Moukarzel, L., Zhu, Y., Derakhshan, F., Hoang, T., Pesci, G., Green, H., Hanlon, E., Gardner, G., Roche, K. L., Abu-Rustum, N., Sonoda, Y., Zivanovic, O., Chi, D., Weigelt, B., & Zamarin, D. (2023). Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer (187). Gynecologic Oncology, 176, S75–S76. https://doi.org/10.1016/j.ygyno.2023.06.573

Clark, H., Huang, Y., de Meritens, A. B., Hou, J., Khoury-Collado, F., St. Clair, C., & Wright, J. (2023). Long-term cancer and non-cancer associated mortality among patients with cervical cancer (1138). Gynecologic Oncology, 176, S99–S100. https://doi.org/10.1016/j.ygyno.2023.06.059

Kulkarni, A., Chen, L., Gockley, A., Khoury-Collado, F., Hou, J., Clair, C. S. T., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals. Gynecologic Oncology, 175, 53–59. https://doi.org/10.1016/j.ygyno.2023.06.007

Konski, A., Deshmukh, S., Klopp, A. H., Yeung, A. R., Westin, S. N., Thompson, J. S., Doncals, D. E., Cantuaria, G. H. C., D’Souza, D. P., Chang, A., Kundapur, V., Mohan, D. S., Haas, M. L., Kim, Y. B., Ferguson, C. L., Pugh, S. L., Kachnic, L. A., & Bruner, D. W. (2023). Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology’s RTOG 1203. Gynecologic Oncology, 175, 176–181. https://doi.org/10.1016/j.ygyno.2023.05.074

Rimel, B. J., Crane, E. K., Hou, J., Nakayama, J., MacDonald, J., Lutz, K., Makker, V., & O’Cearbhaill, R. E. (2023). Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations. Gynecologic Oncology, 174, 148–156. https://doi.org/10.1016/j.ygyno.2023.05.007

Scanlon, L. R., Khaksari, B., Goel, S., Nevadunsky, N. S., Wright, J. D., & Gressel, G. M. (2023). Direct oral anticoagulant (DOACs) prescribing practices of members of the Society of Gynecologic Oncology and American Society of Clinical Oncology. Gynecologic Oncology, 173, 68–73. https://doi.org/10.1016/j.ygyno.2023.04.012

Furey, K. B., Anderson, Z. S., Kuznicki, M. L., Klar, M., Roman, L. D., Wright, J. D., & Matsuo, K. (2023). Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer. Gynecologic Oncology, 173, 122–129. https://doi.org/10.1016/j.ygyno.2023.04.025

Momeni-Boroujeni, A., Vanderbilt, C., Yousefi, E., Abu-Rustum, N. R., Aghajanian, C., Soslow, R. A., Ellenson, L. H., Weigelt, B., & Murali, R. (2023). Landscape of chromatin remodeling gene alterations in endometrial carcinoma. Gynecologic Oncology, 172, 54–64. https://doi.org/10.1016/j.ygyno.2023.03.010

Thomson, C. A., Crane, T. E., Miller, A., Gold, M. A., Powell, M., Bixel, K., Van Le, L., DiSilvestro, P., Ratner, E., Lele, S., Guntupalli, S., Huh, W., Robertson, S. E., Modesitt, S., Casey, A. C., Basen-Engquist, K., Skiba, M., Walker, J., Kachnic, L., & Alberts, D. S. (2023). Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors. Gynecologic Oncology, 170, 11–18. https://doi.org/10.1016/j.ygyno.2022.12.017

Boone, R. M., Praiss, A. M., Huang, Y., Melamed, A., Khoury-Collado, F., Hou, J. Y., Gockley, A., St. Clair, C. M., Hershman, D. L., & Wright, J. D. (2023). Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials. Gynecologic Oncology, 169, 70–77. https://doi.org/10.1016/j.ygyno.2022.11.022

Karia, P. S., Huang, Y., Tehranifar, P., Wright, J. D., & Genkinger, J. M. (2023). Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors. Gynecologic Oncology, 168, 119–126. https://doi.org/10.1016/j.ygyno.2022.11.015

Hou, J. Y., Chapman, J. S., Kalashnikova, E., Pierson, W., Smith-McCune, K., Pineda, G., Vattakalam, R. M., Ross, A., Mills, M., Suarez, C. J., Davis, T., Edwards, R., Boisen, M., Sawyer, S., Wu, H.-T., Dashner, S., Aushev, V. N., George, G. V., Malhotra, M., … Ford, J. M. (2022). Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer. Gynecologic Oncology, 167(2), 334–341. https://doi.org/10.1016/j.ygyno.2022.09.004

Cherston, C., Yoh, K., Huang, Y., Melamed, A., Gamble, C. R., Prabhu, V. S., Li, Y., Hershman, D. L., & Wright, J. D. (2022). Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer. Gynecologic Oncology, 166(3), 552–560. https://doi.org/10.1016/j.ygyno.2022.06.023

Yoh, K., Dioun, S., Gockley, A., Melamed, A., Clair, C. St., Hou, J., Collado, F. K., Wright, J., & Gamble, C. (2022). Lived experience of women diagnosed with a gynecologic cancer in the height of the COVID-19 pandemic in New York City (508). Gynecologic Oncology, 166, S250. https://doi.org/10.1016/s0090-8258(22)01730-9

Diggs, A., Sia, T. Y., Huang, Y., Gockley, A., Melamed, A., Khoury-Collado, F., St. Clair, C., Hou, J. Y., Hershman, D. L., & Wright, J. D. (2022). Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma. Gynecologic Oncology, 166(2), 308–316. https://doi.org/10.1016/j.ygyno.2022.05.018

Marsh, L. A., Aviki, E. M., Wright, J. D., Chen, L., Abu-Rustum, N., & Salani, R. (2022). Sentinel lymph node mapping for endometrial cancer: Opportunity for medical waste reform. Gynecologic Oncology, 166(1), 162–164. https://doi.org/10.1016/j.ygyno.2022.05.008

Guida, F., Dioun, S., Fagotti, A., Melamed, A., Grossi, A., Scambia, G., Wright, J. D., & Tergas, A. I. (2022). Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: Systematic review and meta-analysis. Gynecologic Oncology, 166(1), 181–187. https://doi.org/10.1016/j.ygyno.2022.04.005

Matsuo, K., Khetan, V. U., Brunette, L. L., Jooya, N. D., Klar, M., Wright, J. D., & Roman, L. D. (2022). Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer. Gynecologic Oncology, 165(2), 264–269. https://doi.org/10.1016/j.ygyno.2022.02.015

Matsuo, K., Chen, L., Guo, X. M., Roman, L. D., Klar, M., & Wright, J. D. (2022). Hormonal therapy or chemotherapy for early-stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study. Gynecologic Oncology, 165(2), 353–360. https://doi.org/10.1016/j.ygyno.2022.02.016

Huang, Y., Hou, J. Y., Melamed, A., St. Clair, C. M., Khoury-Collado, F., Gockley, A., Ananth, C. V., Neugut, A. I., Hershman, D. L., & Wright, J. D. (2022). Pathologic characteristics, patterns of care, and outcomes of Asian-Americans and Pacific islanders with uterine cancer. Gynecologic Oncology, 165(1), 160–168. https://doi.org/10.1016/j.ygyno.2022.02.004

Brunette, L. L., Khetan, V. U., Deshpande, R. R., Nusbaum, D. J., Klar, M., Roman, L. D., Wright, J. D., & Matsuo, K. (2022). Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States. Gynecologic Oncology, 164(3), 651–657. https://doi.org/10.1016/j.ygyno.2022.01.002

Zhou, Z. N., Chen, L., Melamed, A., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Gockley, A., Hershman, D. L., & Wright, J. D. (2022). Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer. Gynecologic Oncology, 164(2), 341–347. https://doi.org/10.1016/j.ygyno.2021.12.005

Lara, O. D., Smith, M., Wang, Y., O’Cearbhaill, R. E., Blank, S. V., Kolev, V., Carr, C., Knisely, A., McEachron, J., Gabor, L., Chapman-Davis, E., Cohen, S., Fehniger, J., Lee, Y.-C., Isani, S., Liu, M., Wright, J. D., & Pothuri, B. (2022). COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic. Gynecologic Oncology, 164(2), 304–310. https://doi.org/10.1016/j.ygyno.2021.12.004

Praiss, A. M., Huang, Y., St. Clair, C. M., Melamed, A., Khoury-Collado, F., Hou, J. Y., Gockley, A., Hillyer, G. C., Hershman, D. L., & Wright, J. D. (2022). Long-term outcomes of vaginal hysterectomy for endometrial cancer. Gynecologic Oncology, 164(1), 105–112. https://doi.org/10.1016/j.ygyno.2021.10.082

Matsuo, K., Klar, M., Khetan, V. U., Violette, C. J., Nusbaum, D. J., Muderspach, L. I., Roman, L. D., & Wright, J. D. (2022). Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United States. Gynecologic Oncology, 164(1), 46–52. https://doi.org/10.1016/j.ygyno.2021.10.085